Purchase Order 75H70921P00179
- Not listed
- This federal contract award, valued at $22,149.00, was issued by the Indian Health Service (IHS), a civilian agency, to the prime contractor Cepheid. The contract is for Cepheid's service base plus an additional 2 years and has a firm fixed price. It does not have a set-aside designation. Cepheid is a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The company has received numerous prime federal contracts and subcontracts...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $416,991.94, is for the supply of CEPHEID diagnostic products and has an ultimate completion date of July 30, 2025. The contract is a delivery order with a firm fixed-price pricing type and does not have a set-aside designation. Cepheid is the prime contractor...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Indian Health Service (IHS), a civilian agency. The contract is a Blanket Purchase Agreement (BPA) with a ceiling value of $1,010,160.00 for the provision of CEPHEID LABORATORY REAGENTS, TEST KITS & SUPPLIES. The contract is a firm fixed-price type with a period of performance ending on February 11, 2025. The contract does not have a set-aside designation. Cepheid is the prime...
- This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is for the provision of 4 replacement CEPHEID units with a trade-in allowance, with a total ceiling value of $255,070.43 and a completion date of June 9, 2029. The contract does not have a set-aside designation. Cepheid is the prime contractor and has participated in other federal contract vehicles and...
- This is a firm fixed-price contract awarded by the Indian Health Service (IHS), a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $73,894.16 and is for the delivery of laboratory testing supplies and services, with a period of performance through March 5, 2025. The contract is a Blanket Purchase Agreement (BPA) call, which allows the IHS to continuously procure Cepheid's molecular diagnostic solutions, including...
- This is a firm fixed-price purchase order awarded by the Indian Health Service to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for a CEPHEID SERVICE AGREEMENT to reinstate service and provide a base year plus three option years, with a ceiling value of $32,600.00. The contract supports the Indian Health Service's clinical testing programs by providing Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance...
- The U.S. Indian Health Service (IHS) awarded a $115,600.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for the provision of CEPHEID TEST KITS. The contract has an ultimate completion date of July 10, 2025 and was awarded on January 30, 2024. Cepheid is a prime contractor that provides advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing to various federal agencies,...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the U.S. Department of Health and Human Services' Indian Health Service (IHS) agency. The contract is a $5,000,000 single-award Indefinite Delivery Vehicle (IDV) running from June 17, 2025 to June 30, 2026, which will provide GeneXpert diagnostic systems and associated services. This contract is not designated as a set-aside. Cepheid has also been awarded other significant federal IDV...
- This is a firm fixed-price delivery order awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $29,071.25 contract is for the provision of Cepheid's diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to support clinical testing programs serving the IHS patient population. This award does not have a...
- The Department of Health and Human Services Indian Health Service has awarded a $19,206.10 firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. This contract does not have a set-aside designation. Cepheid will provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to support the Indian Health Service's clinical testing programs. Cepheid is a leading provider of molecular diagnostics...
This federal contract award is for a 4-year service agreement between the Indian Health Service (IHS) and Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for an amount of $66,676.00. The contract has a total ceiling value of $107,560.00 and is a firm fixed-price purchase order that was awarded on September 16, 2021. The place of performance is Crow Agency, MT. This contract does not have a set-aside designation. Cepheid is a leading provider of molecular diagnostic systems and tests, and has received numerous prime federal contracts to supply diagnostic equipment, reagents, and related services to agencies such as the Department of Veterans Affairs and the Defense Logistics Agency. The company has also participated as a subrecipient on federal grant awards focused on improving tuberculosis diagnostics globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $20.9k | 7/22/24 | |
| P00002 | Exercise an Option | $20.0k | 8/24/23 | |
| P00001 | Other Administrative Action | $0 | 8/17/22 | |
| Not listed | Not listed | $66.7k | 9/16/21 |